Effect of combined COX-1 and COX-2 inhibition on platelet aggregation in-vivo
- Conditions
- enhanced clottingthrombosis1003446810014523
- Registration Number
- NL-OMON30233
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
healthy men
Exclusion Criteria
Use of medical drugs, smoking, supersensitivity to aspirin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Amount of aggregation to ADP and epinephrine before and after aspirin at some<br /><br>seconds after the blood left the canula</p><br>
- Secondary Outcome Measures
Name Time Method <p>Amount of aggregation to ADP and arachidonic acid before and after aspirin in a<br /><br>whole blood aggregopmeter , at more than one hour after blood collection</p><br>